U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07422298) titled 'A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants' on Feb. 12.
Brief Summary: The purpose of this study is to evaluate the effect of BMS-986278 on the cardiac repolarization in healthy participants.
Study Start Date: Feb. 17
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: BMS-986278
Specified dose on specified days
DRUG: Placebo
Specified dose on specified days
DRUG: Moxifloxacin
Specified dose on specified days
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Myers Squibb
Disclaimer: Curated by HT Syndication....